What You Should Know: Today, Nucleus RadioPharma the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals has announced an oversubscribed $56 million Series A funding round led by Eclipse and GE HealthCare with participation from Echo Global, Fox…
Continue Reading
Background: Patients with head and neck cancer (HNC) often experience various types and degrees of complications and functional impairment following surgery or radiotherapy. Consequently, these patients require extensive postdischarge rehabilitation, either at home or…
Continue Reading
Point of care alerts are helping John M. Robertson, MD – a family medicine specialist at Family Medical Clinic of Harrogate – to ensure that patients are getting preventative care they need to stay…
Continue Reading
Perfect for use in designing and developing websites, printed files and presentations, stock images, Promotional Materials, Illustrations or Info graphic or any type of design projects.03/
Associated costs for health plan members with cancer are…
What You Should Know:
PathAI Diagnostics, formerly Poplar Healthcare, a leading laboratory services company, today unveiled the world’s first AI-assisted laboratory-developed test for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).MASLD and…
Continue Reading
A Corewell Health study suggests that men with longer prostatic urethras face a higher risk of urinary side effects after prostate cancer radiation therapy. By utilizing a novel MRI metric, researchers found that for…
Continue Reading
Scientists at Purdue University have developed a microRNA therapy designed to slow tumor growth. The technology takes advantage of the tendency of several cancer types to express an excess of surface receptors that bind…
Continue Reading
Britannic have streamlined telephony systems, following the merger of Breast Cancer Care with Breast Cancer Now, so to ensure simple telephone operations for both employees and users.Breast Cancer Care were already using the Britannic…
Continue Reading
Radionetics Oncology has initiated a Phase 1 clinical trial for 68Ga-R8760, a pioneering radioligand imaging agent designed to detect adrenocortical carcinoma. The study, R8760-101 (NCT05999292), focuses on assessing the agent’s safety and dosimetry. Dr….
Continue Reading
What You Should Know:
– Densitas®, a provider of artificial intelligence solutions for breast cancer screening, announced a strategic partnership with Intelerad Medical Systems®, a provider of medical imaging software and services to advance AI-driven…
Continue Reading
